메뉴 건너뛰기




Volumn 122, Issue 3, 2007, Pages 216-223

Accelerated streptokinase in ST-elevation myocardial infarction - a romanian (ASK-ROMANIA) multicenter registry

Author keywords

Acute myocardial infarction; Coronary reperfusion; Streptokinase; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; RETEPLASE; STREPTOKINASE;

EID: 35548997503     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.071     Document Type: Article
Times cited : (4)

References (45)
  • 1
    • 0022640774 scopus 로고
    • Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
    • Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)
    • Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet I (1986) 397-402
    • (1986) Lancet , vol.I , pp. 397-402
  • 2
    • 0023805341 scopus 로고
    • Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
    • ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988) 349-360
    • (1988) Lancet , vol.2 , pp. 349-360
    • ISIS-2 (Second International Study of Infarct Survival) Collaborative Group1
  • 3
    • 0025335032 scopus 로고
    • GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction.
    • Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 336 (1990) 65-71
    • (1990) Lancet , vol.336 , pp. 65-71
    • Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico1
  • 4
    • 0026607185 scopus 로고
    • ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
    • ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 339 (1992) 753-770
    • (1992) Lancet , vol.339 , pp. 753-770
    • ISIS-3 (Third International Study of Infarct Survival) Collaborative Group1
  • 5
    • 0027240597 scopus 로고
    • An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction
    • The GUSTO investigators. An international randomised trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
    • (1993) N Engl J Med , vol.329 , pp. 673-682
    • The GUSTO investigators1
  • 6
    • 0027424433 scopus 로고
    • The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
    • GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
    • (1993) N Engl J Med , vol.329 , pp. 1615-1622
    • GUSTO Angiographic Investigators1
  • 7
    • 0002056787 scopus 로고
    • ISIS-2: 4-year mortality follow-up of 17,187 patients after fibrinolytic and antiplatelet therapy in suspected acute myocardial infarction
    • Baigent C., and Collins R. ISIS-2: 4-year mortality follow-up of 17,187 patients after fibrinolytic and antiplatelet therapy in suspected acute myocardial infarction. Circulation 8 (1993) 1-291
    • (1993) Circulation , vol.8 , pp. 1-291
    • Baigent, C.1    Collins, R.2
  • 8
    • 0003175129 scopus 로고    scopus 로고
    • International Resuscitation Guidelines 2000 - A Consensus on Science
    • International Resuscitation Guidelines 2000 - A Consensus on Science. Resuscitation 46 (2000) 1-447
    • (2000) Resuscitation , vol.46 , pp. 1-447
  • 9
    • 0030847845 scopus 로고    scopus 로고
    • A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction
    • Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators
    • Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction. N Engl J Med 337 (1997) 1124-1130
    • (1997) N Engl J Med , vol.337 , pp. 1124-1130
  • 10
    • 0029066701 scopus 로고
    • More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. The RAPID Investigators
    • Smalling R.W., Bode C., Kalbfleisch J.M., et al. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. The RAPID Investigators. Circulation 91 (1995) 2725-2732
    • (1995) Circulation , vol.91 , pp. 2725-2732
    • Smalling, R.W.1    Bode, C.2    Kalbfleisch, J.M.3
  • 11
    • 0343849937 scopus 로고    scopus 로고
    • Randomised comparison of coronary thrombolysis achieved with double bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators
    • Bode C., Smalling, Berg G., et al. Randomised comparison of coronary thrombolysis achieved with double bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. Circulation 94 (1996) 891-898
    • (1996) Circulation , vol.94 , pp. 891-898
    • Bode, C.1    Smalling2    Berg, G.3
  • 12
    • 0029142436 scopus 로고
    • Randomised double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence
    • International Joint Efficacy Comparison of Thrombolytics. Randomised double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 346 (1995) 329-336
    • (1995) Lancet , vol.346 , pp. 329-336
    • International Joint Efficacy Comparison of Thrombolytics1
  • 14
    • 0034543078 scopus 로고    scopus 로고
    • Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
    • InTIME-II Investigators. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 21 24 (2000) 2005-2013
    • (2000) Eur Heart J , vol.21 , Issue.24 , pp. 2005-2013
    • InTIME-II Investigators1
  • 15
    • 0032542048 scopus 로고    scopus 로고
    • Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase
    • den Heijer P., Vermeer F., Ambrosioni E., et al. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation 98 20 (1998) 2117-2125
    • (1998) Circulation , vol.98 , Issue.20 , pp. 2117-2125
    • den Heijer, P.1    Vermeer, F.2    Ambrosioni, E.3
  • 16
    • 0032578970 scopus 로고    scopus 로고
    • TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators
    • Cannon C.P., Gibson M.C., McCabe C.H., et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation 98 (1998) 2805-2814
    • (1998) Circulation , vol.98 , pp. 2805-2814
    • Cannon, C.P.1    Gibson, M.C.2    McCabe, C.H.3
  • 17
    • 0033612881 scopus 로고    scopus 로고
    • Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial
    • Assessment of the Safety and Efficacy of a New Thrombolytic Investigators
    • Assessment of the Safety and Efficacy of a New Thrombolytic Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 354 (1999) 716-722
    • (1999) Lancet , vol.354 , pp. 716-722
  • 18
    • 85006899353 scopus 로고    scopus 로고
    • Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators
    • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction
    • Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358 (2001) 605-613
    • (2001) Lancet , vol.358 , pp. 605-613
  • 19
    • 0028829271 scopus 로고
    • A randomised trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction
    • Vanderschueren S., Barrios L., and Kerdsinchai P. A randomised trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. Circulation 92 (1995) 2044-2049
    • (1995) Circulation , vol.92 , pp. 2044-2049
    • Vanderschueren, S.1    Barrios, L.2    Kerdsinchai, P.3
  • 20
    • 0032032528 scopus 로고    scopus 로고
    • Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMPASS) Investigators
    • Tebbe U., Michels R., Boland J., et al. Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMPASS) Investigators. J Am Coll Cardiol 31 (1998) 487-493
    • (1998) J Am Coll Cardiol , vol.31 , pp. 487-493
    • Tebbe, U.1    Michels, R.2    Boland, J.3
  • 21
    • 0035822605 scopus 로고    scopus 로고
    • Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)
    • Ross A.M., Molhoek P., Lundergan C., et al. Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II). Circulation 104 (2001) 648-652
    • (2001) Circulation , vol.104 , pp. 648-652
    • Ross, A.M.1    Molhoek, P.2    Lundergan, C.3
  • 22
    • 0036669066 scopus 로고    scopus 로고
    • Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study
    • Simoons M.L., Krzemiñska-Pakula M., Alonso A., et al. Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study. Eur Heart J 23 (2002) 1282-1290
    • (2002) Eur Heart J , vol.23 , pp. 1282-1290
    • Simoons, M.L.1    Krzemiñska-Pakula, M.2    Alonso, A.3
  • 23
    • 0037046221 scopus 로고    scopus 로고
    • Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial
    • Antman E.M., Louwerenburg H.W., Baars H.F., et al. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation 105 (2002) 1642-1649
    • (2002) Circulation , vol.105 , pp. 1642-1649
    • Antman, E.M.1    Louwerenburg, H.W.2    Baars, H.F.3
  • 24
    • 0035651983 scopus 로고    scopus 로고
    • Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial
    • White H. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 358 (2001) 1855-1863
    • (2001) Lancet , vol.358 , pp. 1855-1863
    • White, H.1
  • 25
    • 0035897888 scopus 로고    scopus 로고
    • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
    • Topol E.J. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 357 (2001) 1905-1914
    • (2001) Lancet , vol.357 , pp. 1905-1914
    • Topol, E.J.1
  • 26
    • 0027451880 scopus 로고
    • Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1
    • Ridker P.M., O'Donell C., Marder V.J., and Hennekens C.H. Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1. Ann Intern Med 119 (1993) 530-532
    • (1993) Ann Intern Med , vol.119 , pp. 530-532
    • Ridker, P.M.1    O'Donell, C.2    Marder, V.J.3    Hennekens, C.H.4
  • 27
    • 0027525623 scopus 로고
    • Thrombolysis after GUSTO: a European perspective.
    • Sleight P. Thrombolysis after GUSTO: a European perspective. J Myocard Ischem 5 8 (1993) 25
    • (1993) J Myocard Ischem , vol.5 , Issue.8 , pp. 25
    • Sleight, P.1
  • 29
    • 0034720132 scopus 로고    scopus 로고
    • Thrombolysis medication errors: benefits of bolus thrombolytic agents
    • Cannon C.P. Thrombolysis medication errors: benefits of bolus thrombolytic agents. Am J Cardiol 85 (2000) 17C-22C
    • (2000) Am J Cardiol , vol.85
    • Cannon, C.P.1
  • 30
    • 11144258046 scopus 로고    scopus 로고
    • ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology / American Heart Association task force on practice guidelines
    • ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology / American Heart Association task force on practice guidelines. J Am Coll Cardiol 44 (2004) E1-E212
    • (2004) J Am Coll Cardiol , vol.44
  • 31
    • 0021227043 scopus 로고
    • Intravenous streptokinase in evolving acute myocardial infarction
    • Ganz W., Geft I., Shah P.K., et al. Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol 53 (1984) 1209-1216
    • (1984) Am J Cardiol , vol.53 , pp. 1209-1216
    • Ganz, W.1    Geft, I.2    Shah, P.K.3
  • 32
    • 0022353662 scopus 로고
    • The effects of the rate of intravenous infusion of streptokinase and the duration of symptoms on the time interval to reperfusion in patients with acute myocardial infarction
    • Lew A.S., Laramee P., Cercek B., Rodriguez L., Shah P.K., and Ganz W. The effects of the rate of intravenous infusion of streptokinase and the duration of symptoms on the time interval to reperfusion in patients with acute myocardial infarction. Circulation 72 (1985) 1053-1058
    • (1985) Circulation , vol.72 , pp. 1053-1058
    • Lew, A.S.1    Laramee, P.2    Cercek, B.3    Rodriguez, L.4    Shah, P.K.5    Ganz, W.6
  • 33
    • 0025186686 scopus 로고
    • A double-blind randomized multicenter dose-ranging trial of intravenous streptokinase in acute myocardial infarction
    • Six A.J., Louwerenburg H.W., Braams R., et al. A double-blind randomized multicenter dose-ranging trial of intravenous streptokinase in acute myocardial infarction. Am J Cardiol 65 (1990) 119-123
    • (1990) Am J Cardiol , vol.65 , pp. 119-123
    • Six, A.J.1    Louwerenburg, H.W.2    Braams, R.3
  • 34
    • 1142300263 scopus 로고
    • Endogenous and exogenous thrombolysis
    • Deutsche E. Endogenous and exogenous thrombolysis. Thromb Diath Haemorrh Suppl 47 (1971) :145
    • (1971) Thromb Diath Haemorrh , vol.SUPPL. 47
    • Deutsche, E.1
  • 35
    • 0029878321 scopus 로고    scopus 로고
    • Characteristics and mortality outcome of thrombolysis trial participants and non participants. A population based comparison
    • Jha P., Deboer D., Sykora K., and Naylor C.D. Characteristics and mortality outcome of thrombolysis trial participants and non participants. A population based comparison. J Am Coll Cardiol 27 (1996) 1335
    • (1996) J Am Coll Cardiol , vol.27 , pp. 1335
    • Jha, P.1    Deboer, D.2    Sykora, K.3    Naylor, C.D.4
  • 36
    • 1142288138 scopus 로고    scopus 로고
    • Coronary patency 90 min after intravenous (750,000 U, in 15 min) streptokinase in acute myocardial infarction - TROMBA study
    • [Abstract suppl]
    • Esteves F.P., Esteves P.J., Passos L.C., et al. Coronary patency 90 min after intravenous (750,000 U, in 15 min) streptokinase in acute myocardial infarction - TROMBA study. Eur Heart J 17 (1996) 203 [Abstract suppl]
    • (1996) Eur Heart J , vol.17 , pp. 203
    • Esteves, F.P.1    Esteves, P.J.2    Passos, L.C.3
  • 37
    • 1142276005 scopus 로고    scopus 로고
    • Safety of a new accelerated streptokinase regimen in acute myocardial infarction
    • [Abstract suppl]
    • Anschelevich M., Anschelevich I., and Kochkaryov F. Safety of a new accelerated streptokinase regimen in acute myocardial infarction. Eur Heart J 17 (1996) 203 [Abstract suppl]
    • (1996) Eur Heart J , vol.17 , pp. 203
    • Anschelevich, M.1    Anschelevich, I.2    Kochkaryov, F.3
  • 38
    • 0028039957 scopus 로고
    • Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
    • Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343 (1994) 311-322
    • (1994) Lancet , vol.343 , pp. 311-322
    • Fibrinolytic Therapy Trialists' (FTT) Collaborative Group1
  • 39
    • 0034609252 scopus 로고    scopus 로고
    • Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis
    • Mehta S.R., Eikelboom J.W., and Yusuf S. Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis. Lancet 356 (2000) 449-454
    • (2000) Lancet , vol.356 , pp. 449-454
    • Mehta, S.R.1    Eikelboom, J.W.2    Yusuf, S.3
  • 40
    • 0029111974 scopus 로고
    • Contemporary therapy for cardiogenic shock: The GUSTO-I trial experience
    • Holmes D.R., Bates E.R., Kleiman N.S., et al. Contemporary therapy for cardiogenic shock: The GUSTO-I trial experience. J Am Coll Cardiol 26 (1995) 668-674
    • (1995) J Am Coll Cardiol , vol.26 , pp. 668-674
    • Holmes, D.R.1    Bates, E.R.2    Kleiman, N.S.3
  • 41
    • 0030906005 scopus 로고    scopus 로고
    • Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial
    • Tsang T., Califf R.M., Steebins A.L., et al. Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Am J Cardiol 79 (1997) 1232-1235
    • (1997) Am J Cardiol , vol.79 , pp. 1232-1235
    • Tsang, T.1    Califf, R.M.2    Steebins, A.L.3
  • 42
    • 0023878129 scopus 로고
    • Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction
    • Lewis B.S., Ganz W., Laramee P., et al. Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. Am J Cardiol 62 (1988) 20-24
    • (1988) Am J Cardiol , vol.62 , pp. 20-24
    • Lewis, B.S.1    Ganz, W.2    Laramee, P.3
  • 43
    • 0025875430 scopus 로고
    • Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers
    • Hohnloser S.H., Zabel M., Kasper W., Meinertz T., and Just H. Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 18 (1991) 44-49
    • (1991) J Am Coll Cardiol , vol.18 , pp. 44-49
    • Hohnloser, S.H.1    Zabel, M.2    Kasper, W.3    Meinertz, T.4    Just, H.5
  • 44
    • 0029892835 scopus 로고    scopus 로고
    • Non-invasive prediction of reperfusion and coronary artery patency by continous ST segment monitoring in the GUSTO-I trial
    • Klootwijk P., Langer A., Meij S., et al. Non-invasive prediction of reperfusion and coronary artery patency by continous ST segment monitoring in the GUSTO-I trial. Eur Heart J 17 (1996) 689-698
    • (1996) Eur Heart J , vol.17 , pp. 689-698
    • Klootwijk, P.1    Langer, A.2    Meij, S.3
  • 45
    • 33645515458 scopus 로고    scopus 로고
    • Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
    • Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354 14 (2006) 1477-1488
    • (2006) N Engl J Med , vol.354 , Issue.14 , pp. 1477-1488
    • Antman, E.M.1    Morrow, D.A.2    McCabe, C.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.